LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
7.50
+0.59 (8.54%)
Mar 12, 2026, 4:00 PM EDT - Market closed

LeonaBio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
19.1126.0933.332.5521.236.71
Research & Development
20.1670.6893.7961.4642.7913.29
Other Operating Expenses
-4.13-1.6310--
Total Operating Expenses
39.27100.9125.47104.0264.0220
Operating Income
-39.27-100.9-125.47-104.02-64.02-20
Total Non-Operating Income (Expense)
1.543.967.798.389.170.04
Pretax Income
-37.72-96.94-117.67-95.64-54.85-19.96
Net Income
-37.72-96.94-117.67-95.64-54.85-19.96
Net Income to Common
-37.72-96.94-117.67-95.64-54.85-19.96
Shares Outstanding (Basic)
444441
Shares Outstanding (Diluted)
444441
Shares Change (YoY)
1.93%1.21%0.76%2.20%208.53%235.50%
EPS (Basic)
-9.65-25.20-30.90-25.30-14.90-16.70
EPS (Diluted)
-9.65-25.20-30.90-25.30-14.90-16.70
Free Cash Flow
-52.35-97.2-101.06-73.61-44.67-26.43
Free Cash Flow Per Share
-13.40-25.26-26.58-19.51-12.10-22.09
EBITDA
-38.3-99.93-124.5-103.17-63.54-19.99
EBIT
-39.27-100.9-125.47-104.02-64.02-20
Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q